Abbott has announced that its Navitor™ transcatheter aortic valve implantation (TAVI) system has received CE Mark in Europe for an expanded indication. The approval allows the device to treat people with symptomatic, severe aortic stenosis who are at low or intermediate risk for open-heart surgery. Previously, in 2021, Navitor received
Researchers at NYU Abu Dhabi (NYUAD) have created an ingestible device that uses light to activate gut neurons, offering a novel, non-invasive approach to studying and potentially treating digestive and metabolic disorders The technology, named ICOPS (Ingestible Controlled Optogenetic Stimulation), was developed by Khalil Ramadi, Assistant Professor of Bioengineering at
Cleveland Clinic Abu Dhabi is the first hospital in the Middle East to successfully implant a groundbreaking device to treat a serious, life-threatening heart and vascular condition. The Thoracic Branch Endoprosthesis (TBE) is designed to manage complex Type B aortic dissection, a condition in which a tear develops in the
Get notified about new articles
